Chinese biotech 3SBIO launches up to $712 mln HK IPO - term sheet

May 27 (Reuters) - Chinese biotech company 3SBIO, which delisted from the Nasdaq two years ago, on Wednesday launched an up to $712 million Hong Kong IPO, according to a term sheet seen by Reuters.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.